Skip to main content
. 2020 May 15;11:249. doi: 10.3389/fendo.2020.00249

Table 3.

Factors related to the quality of life of papillary thyroid microcarcinoma patients.

Age Sex Medical expense Follow-up duration
Coef CI p-value Coef 95% CI p-value Coef 95% CI p-value Coef 95% CI p-value
SF-36
PCS −0.245 [−0.472 to−0.018] 0.035* −6.989 [−12.973 to −1.005] 0.023* 5.139 [0.633 to 9.646] 0.026* 0.002 [−0.172 to 0.175] 0.986
PF −0.047 [−0.172 to 0.079] 0.463 −3.393 [−6.647 to −0.138] 0.041* 1.023 [−1.476 to 3.521] 0.418 0.001 [−0.093 to 0.094] 0.989
RP −0.237 [−0.717 to 0.244] 0.330 0.068 [−12.740 to 12.877] 0.992 13.068 [3.852 to 22.285] 0.006* 0.199 [−0.159 to 0.557] 0.272
BP −0.396 [−0.691 to 0.01] 0.009* −6.436 [−14.454 to 1.581] 0.114 6.216 [0.244 to 12.187] 0.042* −0.112 [−0.339 to 0.116] 0.332
GH −0.293 [−0.679 to 0.093] 0.135 −16.067 [−25.834 to −6.300] 0.002* 0.250 [−7.538 to 8.038] 0.949 −0.062 [−0.353 to 0.229] 0.674
MCS −0.104 [−0.376 to 0.167] 0.448 0.989 [−6.230 to 8.209] 0.786 −1.594 [−7.015 to 3.827] 0.560 0.016 [−0.187 to 0.219] 0.875
VT 0.009 [−0.349 to 0.368] 0.958 −3.507 [−12.975 to 5.961] 0.464 −5.455 [−12.501 to 1.592] 0.128 −0.104 [−0.371 to 0.162] 0.439
SF −0.117 [−0.380 to 0.147] 0.381 −4.769 [−11.709 to 2.171] 0.176 5.555 [0.415 to 10.695] 0.034* −0.087 [−0.283 to 0.110] 0.384
RE −0.136 [−0.734 to 0.462] 0.653 −0.822 [−16.699 to 15.056] 0.918 9.848 [−1.905 to 21.602] 0.099 0.065 [−0.381 to 0.511] 0.773
MH −0.024 [−0.321 to 0.273] 0.873 −4.026 [−11.846 to 3.795] 0.309 −0.182 [−6.099 to 5.735] 0.951 −0.277 [−0.490 to −0.063] 0.012*
THYCA-QoL
Neuromuscular 0.305 [0.087 to 0.523] 0.007* −1.481 [−7.510 to 4.547] 0.626 0.000 [−4.540 to 4.54.] 1.000 0.104 [−0.064 to 0.273] 0.222
Voice 0.180 [−0.075 to 0.435] 0.164 −4.718 [−11.481 to 2.045] 0.169 1.515 [−3.618 to 6.648] 0.559 −0.099 [−0.290 to 0.093] 0.309
Concentration 0.154 [−0.094 to 0.402] 0.220 1.065 [−5.562 to 7.692] 0.750 −1.515 [−6.491 to 3.461] 0.547 0.043 [−0.144 to 0.229] 0.651
Sympathetic 0.028 [−0.284 to 0.341] 0.857 −0.944 [−9.223 to 7.335] 0.821 1.515 [−4.705 to 7.734] 0.630 0.052 [−0.181 to 0.284] 0.661
Throat/mouth −0.008 [−0.247 to 0.232] 0.950 −0.223 [−6.574 to 6.128] 0.944 −1.010 [−5.782 to 3.762] 0.675 0.058 [−0.120 to 0.236] 0.519
Psychological 0.217 [−0.073 to 0.506] 0.141 9.064 [1.530 to 16.599] 0.019* −3.598 [−9.398 to 2.203] 0.221 0.100 [−0.118 to 0.318] 0.364
Sensory 0.174 [−0.131 to 0.479] 0.259 5.556 [−2.504 to 13.615] 0.174 −7.197 [−13.126 to 1.267] 0.018* 0.048 [−0.181 to 0.277] 0.678
Problems with scar 0.099 [−0.251 to 0.448] 0.576 5.144 [−4.070 to 14.358] 0.270 −2.272 [−9.234 to 4.690] 0.518 0.047 [−0.214 to 0.307] 0.723
Felt chilly −0.101 [−0.634 to 0.432] 0.707 9.102 [−4.901 to 23.105] 0.200 −2.273 [−12.895 to 8.349] 0.672 0.119 [−0.278 to 0.516] 0.553
Tingling hands/feet 0.175 [−0.077 to 0.426] 0.171 0.578 [−6.162 to 7.319] 0.865 −0.758 [−5.825 to 4.310] 0.767 0.099 [−0.090 to 0.287] 0.300
Gained weight −0.075 [−0.447 to 0.298] 0.691 −0.487 [−10.372 to 9.398] 0.922 −3.030 [−10.436 to 4.376] 0.418 0.222 [−0.052 to 0.496] 0.112
Headache −0.044 [−0.414 to 0.326] 0.812 5.205 [−4.538 to 14.949] 0.291 2.273 [−5.087 to 9.632] 0.541 0.005 [−0.271 to 0.281] 0.971
Less interest in sex −0.436 [−0.921 to 0.049] 0.078 −5.662 [−18.698 to 7.374] 0.390 −12.121 [−21.618 to −2.623] 0.013* 0.220 [−0.145 to 0.585] 0.234
FoP-Q-SF
Physical health −0.004 [−0.019 to 0.011] 0.621 0.481 [0.096 to 0.866] 0.015* −0.292 [−0.585 to 0.001] 0.051 −0.004 [−0.015 to 0.007] 0.466
Social family 0.003 [−0.010 to 0.016] 0.696 0.308 [−0.031 to 0.647] 0.074 −0.254 [−0.507 to 0.000] 0.050 0.001 [−0.009 to 0.010] 0.875
*

p < 0.05.